Associations of Clinical Factors and Blood Groups With the Severity of COVID-19 Infection in Makkah City, Saudi Arabia

por Shesha, Nashwa, Melebari, Sami, Alghamdi, Saad, Refaat, Bassem, Naffadi, Hind, Alquthami, Khalid
Publicado 2022

Promising Lead Compounds in the Development of Potential Clinical Drug Candidate for Drug-Resistant Tuberculosis

por Alghamdi, Saad, Rehman, Shaheed Ur, Shesha, Nashwa Talaat, Faidah, Hani, Khurram, Muhammad, Rehman, Sabi Ur
Publicado 2020

Biomarkers for Breast Adenocarcinoma Using In Silico Approaches

por Pandi, Jhansi, Arulprakasam, Ajucarmelprecilla, Dhandapani, Ranjithkumar, Ramanathan, Saikishore, Thangavelu, Sathiamoorthi, Chinnappan, Jayaprakash, Vidhya Rajalakshmi, V., Alghamdi, Saad, Shesha, Nashwa Talaat, Prasath, S.
Publicado 2022

Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies

por Jamal, Qazi Mohammad Sajid, Ahmad, Varish, Alharbi, Ali H, Ansari, Mohammad Azam, Alzohairy, Mohammad A, Almatroudi, Ahmad, Alghamdi, Saad, Alomary, Mohammad N., AlYahya, Sami, Shesha, Nashwa Talaat, Rehman, Suriya
Publicado 2021